Wellster Healthtech Group announces a further $20M in funding, just six months after raising $40M. Wellster is thus closing its series B. The latest funding is provided by Claret Capital, an investor in the FemTech platform Bellabeat and Israel tech VC Mangrove Capital Partners who’s other healthtech investments include K Health and Flo. Wellster integrates telemedicine with digital services, to provide patients with direct access to treatment for everyday health issues—such as mental health, reproductive health, hair loss and skin conditions. To date, it has served over 1.5 million patients. Ease of access to medical care and the prioritization of patients’ needs are at the centre of Wellster’s platforms. The HealthTech company partners closely with Germany’s leading medical professionals to provide the highest standards.
Wellster intends to use the $60M funding to launch a women’s healthcare brand to accompany their male-focused service, Spring. This new service will offer treatments for a range of intimate and lifestyle health concerns. Wellster was founded in 2018 by Dr. Manuel Nothelfer and Nico Hribernik to provide more people with easy access to effective medical treatments. Wellster has developed its platforms to be the primary point of contact for anybody seeking help with their health issues. More than 1.5 million individuals have used the service since it went online.